- The Wall Street Journal•4 hours ago
A trio of pharmaceutical companies is financing an effort by Aquinnah Pharmaceuticals Inc. to use a new approach to tackling neurological diseases that have long frustrated drugmakers.
- Zacks•18 hours ago
Apart from the usual earnings and revenue numbers, investors will be focused on the performance of Celgene's (CELG) key products and its pipeline progress.
- Motley Fool•19 hours ago
Which drug stock wins in a head-to-head matchup between Celgene and Merck?
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||125.52 x 100|
|Ask||126.00 x 400|
|Day's Range||123.75 - 126.22|
|52 Week Range||94.42 - 127.64|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||50.41|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|